Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study

Stephanie M Ware1, James D Wilkinson2, Muhammad Tariq3

  • 1Departments of Pediatrics and Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN.

Insights

Genetic testing identifies the cause of pediatric cardiomyopathy in many children, even those with no family history. Routine genetic testing is recommended due to significant diagnostic yield and practice variations.

Area of Science:

  • Genetics
  • Pediatrics
  • Cardiology

Background:

  • Pediatric cardiomyopathy is a serious genetic disorder with high mortality.
  • Current genetic testing guidelines exist but are inconsistently applied.
  • Data on clinical testing practices and diagnostic yield in children are limited.

Purpose of the Study:

  • To identify genetic causes of cardiomyopathy in children.
  • To investigate clinical genetic testing practices and their diagnostic yield.
  • To support routine genetic testing for pediatric cardiomyopathy.

Main Methods:

  • Exome sequencing was performed on 152 pediatric probands with familial or idiopathic cardiomyopathy from 14 North American institutions.
  • Rare variants in 37 known cardiomyopathy genes were assessed using clinical interpretation guidelines.
  • Clinical genetic testing history and family history were recorded.

Main Results:

  • A molecular cause was identified in 53% of children who underwent prior clinical genetic testing.
  • An additional 21% of children without prior testing received a molecular diagnosis via exome sequencing.
  • Genetic testing rates varied widely (0% to 97%) across participating sites.

Conclusions:

  • A definitive molecular genetic diagnosis is achievable in a significant proportion of pediatric cardiomyopathy cases.
  • Significant practice variations in genetic testing necessitate standardization.
  • Routine genetic testing for both familial and idiopathic pediatric cardiomyopathy is supported by these findings.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
117
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
179
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
118
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
162
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
102